Scientific article
English

Prognostic Utility of Total 68Ga-DOTATATE-Avid Tumor Volume in Patients with Neuroendocrine Tumors

Published in

Gastroenterology

Publication date

2017

Abstract

Survival times vary among patients with neuroendocrine tumors (NETs)-even among those with the same site, stage, and grade of primary tumor. This makes it difficult to select treatment for patients with unresectable NETs, because some patients can survive decades without treatment. 68Gallium-DOTATATE positron emission tomography with computed tomography (68Ga-DOTATATE PET/CT) is a sensitive imaging technique for detection of NETs. We investigated the prognostic accuracy of 68Ga-DOTATATE PET/CT analysis of tumor volume in patients with NETs.

Keywords

  • Pancreas
  • Radiology
  • Survival
  • Tumor size

Citation (ISO format)

TIROSH, Amit et al. Prognostic Utility of Total 68Ga-DOTATATE-Avid Tumor Volume in Patients with Neuroendocrine Tumors. In: Gastroenterology, 2017. doi: 10.1053/j.gastro.2017.11.008

Main files (1)

Article (Accepted version)

Identifiers

Journal ISSN

0016-5085
463views
1downloads

Technical informations

Creation

05/12/2017 10:39:00

First validation

05/12/2017 10:39:00

Update

15/03/2023 07:41:01

Status update

15/03/2023 07:41:00

Last indexation

31/10/2024 09:11:47
All rights reserved by Archive ouverte UNIGE and the University of Geneva
OpenAIRE Indexed & Validated